Interest of Clomiphene Citrate in Patients With Non-obstructive Azoospermia on the Quantity of Sperm Cells

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

January 31, 2026

Primary Completion Date

January 31, 2029

Study Completion Date

January 31, 2029

Conditions
Azoospermia, Nonobstructive
Interventions
DRUG

Clomifene Citrate

"After randomization, the andrologist will give a prescription with the first three months of treatment (Clomifene Citrate or placebo) to be collected to the local hospital pharmacy. The andrologist will be blind of the treatment arm.~Treatment unit and their shipment to local pharmacy will be provided and organized by the East group pharmacy of the Hospices Civils of Lyon which is the coordination pharmacy for this study. Prescription and delivery will be renewed for three months at the 3 month and 6 months visit.~The experimental treatment consists in a daily dose of 50mg of Clomifene Citrate per os during 9 months followed by a second TESE if no spermatozoid has been obtained from semen. The dose level was set according to Chua et al 2013 (cf 1.2.2). One capsule containing 50 mg of CC will be orally administered in the morning every day."

OTHER

Placebo

The placebo treatment consists in a daily dose of 50mg of lactose monohydrate per os during 9 months followed by a second TESE if no spermatozoid has been obtained from semen. The capsule containing the placebo will have the exact same size, weight, color, taste and will be delivered in the exact same condition as the experimental treatment capsule.

Trial Locations (1)

Unknown

Hospices Civils de Lyon, Hôpital Femme-Mère-Enfant, Bron

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER